Dr Zhu Li, the Chief Strategy Officer of Nanjing Legend Biotechnology Co., visited Converd and had in-depth communication with Dr. Hu Fang, Chairman of Converd, and the R&D team of Converd on the research and development of oncolytic virus and cell therapy, as well as discussed related project cooperation.